Table 2.
Infectious disease incidence and type during follow-up in the intention-to-treat group (Mean [CI95])
| EF group | SF group | All infants | |
|---|---|---|---|
| n | 419 | 347 | 771 |
| Infectious disease†(%) | 31.0* | 40.6 | 35.4 |
| Upper respiratory tract infections (%) | 22.0 | 26.6 | 24.1 |
| Otitis (%) | 5.2 | 8.3 | 6.6 |
| Acute diarrhoea (%) | 3.5* | 6.8 | 5.0 |
| Lower respiratory tract infectious disease (%) | 5.2 | 4.3 | 5.8 |
| Genital and urinary infectious disease (%) | 0.2 | 0.2 | 0.2 |
| Dermatologic infectious disease (%) | 0.7 | 1.1 | 0.9 |
| Ophthalmologic infectious disease (%) | 1.6 | 1.4 | 1.5 |
| Virus-related dermatologic infectious disease (%) | 0.9 | 1.4 | 1.1 |
| Monthly number of infectious diseases (n) | 0.23 [0.18; 0.27] | 0.25[0.21; 0.30] | 0.24[0.21; 0.27] |
p < 0.05 versus SF (Student’s t-test or χ2/Fisher's exact test).
Percent of infants with at least one infectious disease during follow-up.